DocGo enters $50 million-plus amended credit deal with Perceptive, issues warrant
DocGo and its subsidiaries entered into an amended and restated credit agreement on October 1, 2026, with Perceptive Credit Holdings IV as administrative agent, replacing a prior Citibank-led revolving facility that was terminated the same day. The new term loans total $102 million in committed facilities, with a stated maturity of December 6, 2029, and the company issued a warrant for 4,000,000 shares at $0.5039 per share as part of the deal, which could dilute existing holders.
Key points
- Term loans include $52 million continued from prior debt, $12.5 million new Term Loan B, $12.5 million Term Loan C tied to the Merger, and $25 million delayed draw Term Loan D
- Term SOFR with a 3.50% floor plus a 7.50% margin; maturity December 6, 2029
- Warrant to purchase 4,000,000 common shares at $0.5039 per share, fully vested, exercisable through the tenth anniversary of October 1, 2026
- Ambulnz began managing Hicuity's non-clinical operations effective October 1, 2026; 98,992,347 common shares were outstanding as of October 1, 2026
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.